Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 06, 2022
This week marks the third African Medicines Regulatory Harmonization (AMRH) week—a critical touch point in ongoing efforts to expand access to quality-assured medicines across the African continent. However, a big concern looms: how to best ensure long-term sustainable funding for regulatory systems...
Blog Post
November 22, 2022
What progress has India made in the past 4 years in developing information systems that are essential to successfully conduct HTA and inform priority-setting decisions? We highlight three initiatives that have improved the availability of information on cost and quality of life in India, identify re...
Blog Post
November 21, 2022
As the world faces multiple crises and the economic and health scars left by the pandemic are still evident, it is clear that governments are unlikely to sustain pandemic-era health spending increases in this recovery phase. How can LMICs align their plans and discourse around universal health cover...
Blog Post
November 17, 2022
How does public health surveillance work, and how can it be done better? Amanda Glassman tackles these questions with Dr. Oliver Morgan of the WHO and Dr. Theo Vos of the Institute for Health Metrics and Evaluation. Together, they examine the successes and limitations of public health surveillance d...
Blog Post
October 13, 2022
On this episode of Pandemic Proof, Dr. Ayoade Alakija, the World Health Organization’s Special Envoy for the Access to COVID-19 Tools Accelerator (ACT-A) and co-chair of the African Union’s African Vaccine Delivery Alliance, joins Javier Guzman to discuss global cooperation during health emergencies...
Blog Post
October 06, 2022
Despite alleged “lessons learned” from the COVID-19 pandemic about the need for early containment, getting the messaging right, and a swift rollout of diagnostics, vaccines, and therapeutics, we have seen the same blunders yet again in the monkeypox response, highlighting the inequities in the syste...
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.